Ysios Biofund II Innvierte

Address: 
Ysios Biofund II Innvierte
Spain
ES
Registration country: 
Spain
ISIC Code: 
6430
Company type: 
Venture capital fund investing in biotech, medtech and diagnostic companies across Europe with a special interest in Spain.
Overview: 
Ysios BioFund II Innvierte has a strategy similar to predecessor fund Ysios BioFund I, (currently under divestment) in that it aims to invest in biotech, medtech and diagnostic companies across Europe with a special interest in Spain. The fund will finance up to 15 early-stage (start-up) and development phase companies with disruptive products, platforms or technologies that address unmet medical needs. Ysios BioFund II Innvierte has a strengthened and expanded investor base, attracting both returning investors as well as new investors. These include institutional investors both at a national and international level, including CDTI (Spanish Ministry of Economy) through its Innvierte program; the European Investment Fund (EIF) and the European Commission through InnovFin SME Venture Capital, a financial instrument developed under the EU Framework Programme for Research and Innovation Horizon 2020; pension funds such as Orza and Lagun Aro; Banc Sabadell (BIDSA) and private investors.